MRSHMarsh McLennan
$175.71-9.1% 1Y
$175.71
$157.3252 weeks$204.92
MRSH as reported
Marsh McLennan reported $27.9B of revenue over the trailing twelve months, +8.3% on the year before. 10 reported series are charted on this page, each one as filed.
$27.9B
Revenue, trailing twelve months · to Q2 2026 · +8.3% against the twelve months before
- Net income
- $3.98B
Net income · −3.6% year on year · trailing twelve months to Q2 2026
- Free cash flow
- $4.77B
Free cash flow · +2.4% year on year · trailing twelve months to Q2 2026
- Operating margin
- 21%
Operating margin · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $27.9B | +8.3% | Q2 2026 |
| Net income | $3.98B | −3.6% | Q2 2026 |
| EPS | $8.18 | −1.9% | Q2 2026 |
| Operating margin | 21% | n/a | Q2 2026 |
| Net margin | 14% | n/a | Q2 2026 |
| ROE | 27% | n/a | Q2 2026 |
| ROA | 6.9% | n/a | Q2 2026 |
| ROIC | 15% | n/a | Q2 2026 |
| Free cash flow | $4.77B | +2.4% | Q2 2026 |
| P/E | 21.5 | n/a | today |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

Marsh McLennan (MRSH) · Revenue and profitRevenue and profitMarsh McLennan (MRSH)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
On our screens:Stocks that buy back more than they dilute
Insurance Brokers
The closest names by size in the same industry